Trade-Offs between Vaccine Effectiveness and Vaccine Safety: Personal versus Policy Decisions [0.03%]
疫苗有效性和安全性的权衡：个人与政策抉择之间的差异
Semra Ozdemir,Sean Ng,Vinh Anh Huynh et al.
Semra Ozdemir et al.
Objective: We aimed to investigate whether individuals' trade-offs between vaccine effectiveness and vaccine safety vary if they are asked to consider the perspective of a policymaker making decisions for others compared ...
Estimating Cumulative Health Care Costs of Childhood and Adolescence Autism Spectrum Disorder in Ontario, Canada: A Population-Based Incident Cohort Study [0.03%]
加拿大安大略省儿童及青少年自闭症医疗保健累积费用的估计：基于人群的定群研究
Claire de Oliveira,Bryan Tanner
Claire de Oliveira
Background: Few studies have estimated cumulative health care costs post-diagnosis for individuals with autism spectrum disorder (ASD). Objectives: ...
Cost-Effectiveness of Non-pharmacological Interventions for Mild Cognitive Impairment and Dementia: A Systematic Review of Economic Evaluations and a Review of Reviews [0.03%]
轻度认知障碍和痴呆非药物干预的成本效益：经济评估及综述的系统性审查
Gillian Eaglestone,Evdoxia Gkaintatzi,Harmony Jiang et al.
Gillian Eaglestone et al.
Background: Dementia prevalence is increasing, with no cure at present. Drug therapies have potential side effects and risk of mortality. People with dementia are frequently offered non-pharmacological interventions to im...
Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15 [0.03%]
关于 ONASEMENGENE ABEPARVOVEC 治疗无症状期脊髓性肌萎缩的疗效和经济性的评估报告——对 NHS 组织外部评审小组意见书第 15 章部分审评的意见
Marty Chaplin,Rebecca Bresnahan,Nigel Fleeman et al.
Marty Chaplin et al.
As part of the National Institute for Health and Care Excellence (NICE) highly specialised technology (HST) evaluation programme, Novartis submitted evidence to support the use of onasemnogene abeparvovec as a treatment option for patients ...
Hospital Resource Utilization and Costs in Patients with Heart Failure in France [0.03%]
法国心力衰竭患者资源利用及费用分析
Frank Chemouni,Tiffany Chihiro Nishikawa,Harinala Groyer et al.
Frank Chemouni et al.
Background and objectives: Heart failure (HF) is one of the leading causes of morbidity and mortality, and economic burden on the healthcare system. The aim of this study was to estimate the current hospital resource util...
Budget Impact Analysis of Risperidone Use and Adverse Event Monitoring in Autism Spectrum Disorder in Brazil: Assessment of Theoretical Versus Real Data [0.03%]
巴西自闭症光谱紊乱中利培酮使用的预算影响分析：理论与真实数据下的不良事件监测评估
Luis Phillipe Nagem Lopes,Alexander Itria,Luciane Cruz Lopes
Luis Phillipe Nagem Lopes
Background and aims: Risperidone is used in autism spectrum disorder (ASD) to manage aggressive behavior. Budget impact analysis (BIA) assists managers in promoting more sustainable health systems; however, it is unclear ...
Madeeha Malik,Ning Yan Gu,Azhar Hussain et al.
Madeeha Malik et al.
Background: To utilize EQ-5D in economic evaluations, a societal-based value set is needed. To date, no value sets exist for any EQ-5D instrument in Pakistan. Previous EQ-5D studies conducted in Pakistan 'borrowed' health...
Retrospective Comparison of Survival Projections for CAR T-Cell Therapies in Large B-Cell Lymphoma [0.03%]
回顾性比较用于大型B细胞淋巴瘤的CAR-T细胞疗法生存预测的方法
Elisabeth F P Peterse,Elisabeth J M Verburg-Baltussen,Alexa Stewart et al.
Elisabeth F P Peterse et al.
Background: Durable remission has been observed in patients with relapsed or refractory (R/R) large B-cell lymphoma (LBCL) treated with chimeric antigen receptor (CAR) T-cell therapy. Consequently, hazard functions for ov...
Characteristics and Quality Appraisal of the Economic Evaluations Done in Ethiopia: A Systematic Review [0.03%]
埃塞俄比亚经济评价的特点和质量审查：系统综述
Bereket Bahiru Tefera,Desalegn Getnet Demsie,Adane Yehualaw et al.
Bereket Bahiru Tefera et al.
Background: Health economic evaluation identifies, measures, values, and compares alternative strategies to efficiently allocate scarce resources. The validity, methodological quality, and generalizability of economic eva...
Model and Empirical Data-Based Cost-Utility Studies of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Protocol of a Systematic Review on Methodology and Quality [0.03%]
基于模型和实证数据的连续葡萄糖监测在1型糖尿病患者中的成本效用研究：系统性回顾的方法学与质量的方案研究
L A de Jong,X Li,S Emamipour et al.
L A de Jong et al.
Introduction: This review aims to critically appraise differences in methodology and quality of model-based and empirical-data-based cost-utility studies to address key limitations, opportunities, and challenges to inform...